Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 323
Selected: 0
NCT IDTitle
NCT00570531Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
NCT05162846Michigan Genetic Hereditary Testing (MiGHT)
NCT03101566Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
NCT04194554A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
NCT03842696Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
NCT00151073Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate
NCT02485470Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy
NCT02763033Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
NCT04396808Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
NCT06539468Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients
NCT04727710Testing the Effect of Mindfulness for Prostatectomy Outcomes
NCT02013453A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer
NCT03194373Phase II Trial Evaluating the Efficacy of Palbociclib in Combination With Carboplatin for the Treatment of Unresectable Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT02409134Cognitive Function and Patient-Reported Quality of Life Outcomes Investigation in Patients Taking Vorinostat
NCT03781986APG-115 in Salivary Gland Cancer Trial
NCT00967824Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer
NCT02331368Phase 2 Multi-center Study of Anti-PD-1 During Lymphopenic State After HDT/ASCT for Multiple Myeloma
NCT03617484Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
NCT02492867A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
NCT00151047Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer
NCT00858585Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study
NCT01921296Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients
NCT01522937A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer
NCT04272645Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer
NCT01663285Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)
NCT00724568Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma
NCT04518748Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
NCT03286114Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab
NCT01409681A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer
NCT00156312Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine
NCT01029054Carfilzomib and Lenalidomide With Dexamethasone Combination in Newly Diagnosed, Previously Untreated Multiple Myeloma
NCT01528865Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma
NCT03352427Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations
NCT00156273Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer
NCT00242190Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
NCT00148135Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
NCT00134355Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer
NCT00810602Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
NCT01750567A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL
NCT00141765Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
NCT06094621Effect of Pre-operative Virtual Visits on Patients With Head and Neck Cancer Undergoing Surgery
NCT05038332Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
NCT04773197Evaluating a Tailored Cognitive Behavioral Therapy for Adolescent and Young Adult Cancer Patients
NCT01389076Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
NCT00176813Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
NCT02762513Expansion Trial for Axitinib In Head And Neck Cancer
NCT00726375The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
NCT01794481Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy
NCT01896050Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer
NCT06914479Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors